Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Belgosuc is a Belgian-based manufacturer specializing in the production of high-quality sugar-based ingredients and semi-finished products for the food and pharmaceutical industries. The company provides a wide range of liquid and solid sweeteners, including invert sugars, glucose syrups, and customized blends used as excipients in medicinal syrups and suspensions. Following its acquisition by Lantic Inc. (a subsidiary of Rogers Sugar Inc.) in 2021, Belgosuc has expanded its global reach while maintaining its focus on specialized sugar solutions. Their pharmaceutical offerings are produced under strict quality standards suitable for use in healthcare applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Belgosuc.